Back to top

Top Ranked Income Stocks to Buy for November 30th

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, November 30th:

Cummins Inc. (CMI - Free Report) : This manufacturer of diesel and natural gas engines has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.6% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 2.63%, compared with the industry average of 1.14%. Its five-year average dividend yield is 2.51%.

Cummins Inc. Dividend Yield (TTM)

Cummins Inc. Dividend Yield (TTM)

Cummins Inc. dividend-yield-ttm | Cummins Inc. Quote

Vector Group Ltd. (VGR - Free Report) : This tobacco company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 7.13%, compared with the industry average of 2.10%. Its five-year average dividend yield is 7.95%.

Vector Group Ltd. Dividend Yield (TTM)

Vector Group Ltd. Dividend Yield (TTM)

Vector Group Ltd. dividend-yield-ttm | Vector Group Ltd. Quote

Toyota Motor Corporation (TM - Free Report) : This manufacturer of passenger vehicles has witnessed the Zacks Consensus Estimate for its current year earnings advancing 5.7% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 2.80%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.72%.

Banco Santander-Chile (BSAC - Free Report) : This retail banking services provider has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.

This Zacks Rank #2 (Buy) company has a dividend yield of 2.98%, compared with the industry average of 2.31%. Its five-year average dividend yield is 3.78%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>



More from Zacks Zacks #1 Rank Additions

You May Like